XML 44 R32.htm IDEA: XBRL DOCUMENT
v3.23.3

Fair Value Measurements - Estimated Fair Value of Significant Unobservable Inputs (Details) - Humabs | Sep. 30, 2023
--- | ---
Clinical and Regulatory Milestones | Probability of achievement | Minimum |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.144
Clinical and Regulatory Milestones | Probability of achievement | Maximum |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.600
Clinical and Regulatory Milestones | Probability of achievement | Weighted Average |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.430
Clinical and Regulatory Milestones | Discount rate | Minimum |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.127
Clinical and Regulatory Milestones | Discount rate | Maximum |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.133
Clinical and Regulatory Milestones | Discount rate | Weighted Average |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.130
Commercial Milestones | Probability of achievement |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.291
Commercial Milestones | Volatility |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.700
Commercial Milestones | Discount rate |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.110

X
- Definition Value of input used to measure contingent consideration liability from business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=vir_HumabsBiomedSAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=vir_ClinicalAndRegulatoryMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=vir_MeasurementInputProbabilityRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_WeightedAverageMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=vir_CommercialMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=vir_MeasurementInputExpectedRevenueVolatilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |